Healia Clinical Trials Information Database

Massage Therapy for Osteoarthritis of the Knee

The study is a randomized, controlled clinical trial that investigates the efficacy ogf massage therapy for 66 patients with pain secondary to osteoarthritis of the knee. It is a wait-list design where subjects and randomly assigned to either Group A or Group B. Group A receives two months of massage while Group B is wait-listed, receives two months of usual care. At the conclusion of the wait period, Group B receives two months of massage. In all cases, subjects continue to receive conventional medical care for their OA symptoms.

Outcome measures include a WOMAC questionnaire, a visual analog pain scale, time to walk fifty feet and range of motion of the knee (using a goniometer). A research assistant, competent in appropriate subject assessment obtains the outcome measures. Change in medication use is tracked by the use of patient diaries. Assessments of subjects, occurs at baseline, and week 8 and 16 in both the intervention and control groups.

Description

The Yale-Griffin Prevention Research Center has received funding from the Centers for Disease Control and Prevention to conduct the Complementary and Alternative Medicine (CAM) Outcomes Research Project (CORP). CORP includes a systematic review of the CAM literature and the development of pilot studies assessing selected CAM interventions. The first year efforts of the CORP research team have culminated in the selection of pilot studies involving three public health priority conditions (attention deficit hyperactivity disorder, asthma, and osteoarthritis) and common CAM interventions. A pilot study investigating the effects of a massage therapy intervention for osteoarthritis is detailed in this application.

Osteoarthritis (OA), the most common form of arthritis, is a slowly progressive degenerative disease of joint cartilage that afflicts 30 million Americans (Praemer A, Furner S, Rice D. Musculoskeletal Conditions in the United States, p 40: American Academy of Orthopaedic Surgeons, 1992). It becomes more prevalent with advancing age (Peyron JG. Osteoarthritis: The Epidemiologic ViewPoint. Clin Orthop, 213:13-19, 1986). Nearly half of America’s elderly suffer from osteoarthritis, and arthritis is the most frequently reported chronic condition in the elderly (Praemer A, Furner S, Rice D. Musculoskeletal Conditions in the United States, p 36: American Academy of Orthopaedic Surgeons, 1992).

Osteoarthritis affects approximately 3 out of every 100 Americans below age 45 and more than a quarter of Americans between the ages of 45 and 64 suffer from this disabling disease (National Center for Health Statistics. Current Estimates from the National Health Interview Survey, 1988; Vital and Health Statistics. Series 10: No. 173, DHHS Pub. No. (PHS) 89-1501. Public Health Service, Hyattsville, MD, Oct. 1989; Kelsey JL, Hochberg MC. Epidemiology of Chronic Musculoskeletal Disorders. Am Rev Public Health, 91:379-401, 1988).

Osteoarthritis of the hip or knee is particularly disabling because it limits ambulation, but the affliction also strikes the hands, the spine, and the feet with the same destructive joint process (Felson DT. Epidemiology of Osteoarthritis: Prevalence and Risk Factors. Osteoarthritis Disorders, American Academy of Orthopaedic Surgeons, 1995). The endpoint of the OA disease process is total loss of joint cartilage in the affected area and the need for joint replacement.

The high prevalence of arthritis in the population is reflected in the economic burden engendered to treat those afflicted. The total cost of conventional treatments for arthritis in 1988, for example, was estimated at 54.6 billion dollars (Lazenby HC, Letsch SW. National Health Expenditures 1989; Health Care Financing Review, 12(2):1-26, 1990). Conventional treatments for OA include pain medication (NSAIDS and cox-2 inhibitors), exercises, hot/cold therapy, steroid injections and, eventually, surgery to repair the joint (Felson DT. Epidemiology of Osteoarthritis: Prevalence and Risk Factors. Osteoarthritis Disorders, American Academy of Orthopaedic Surgeons, 1995). Despite conventional treatment, OA is a progressive disease that frequently leads to chronic pain and disability.

Massage therapy is proposed as an effective treatment for diminishing the symptoms and improving the disease course of osteoarthritis. Massage therapy can accomplish these goals by increasing local circulation to the affected joint, improving the tone of supportive musculature, enhancing joint flexibility and relieving pain (J Spinal Cord Med 2001 Spring; 24(1): 54-62.).

Massage therapy has been evaluated and found to have effectiveness as an adjunct treatment for pain secondary to cancer (Effects of massage on pain intensity: analgesics and quality of life in patients with cancer pain: A pilot study of a randomized clinical trial conducted within hospice care delivery. Wilkie, DJ et al.) as well as low back pain syndrome (Preyde, M. Effectiveness of massage therapy for subacute low-back pain. Journal Burn Care & Rehab 2000; 21(3): 189-193.). It also has been shown to be beneficial for patients with chronic pain following spinal cord injury (Nayak S, Matheis RJ, Agostinelli S, Shiflett SC. The use of complementary and alternative therapies for chronic pain following spinal cord injury: a pilot survey. CMAJ 2000; 162(13): 1815-1820). In a randomized, open clinical trial, a series of classical Swedish massage therapy sessions was found to be as effective as conventional analgesic therapy for chronic rheumatic pain. (Ernst E. Complementary and alternative medicine for pain management in rheumatic disease. Current Opinion in Rheum 2002; 14:58-62). However, to date, no study has specifically evaluated the effectiveness of massage therapy for osteoarthritis.

The proposed study is a randomized, controlled clinical trial to investigate the efficacy of massage therapy for patients with pain secondary to osteoarthritis of the knee. It is a wait-list design where subjects will be randomly assigned to either Group A or Group B. Group A will receive two months of massage while Group B is wait-listed, receiving two months of usual care. At the conclusion of the wait period, Group B will receive two months of massage. In all cases, subjects will continue to receive conventional medical care for their OA symptoms.

Outcome measures will include a WOMAC questionnaire (see Appendix A), a visual analog pain scale (see Appendix B), time to walk fifty feet, and range of motion of the knee (using a goniometer). An athletic trainer, competent in appropriate subject assessment, will obtain the outcome measures (see Appendix C for data collection form). Change in medication use will be tracked by the use of patient diaries (see Appendix D). Assessment of subjects will occur at baseline, and weeks 8 and 16 in both the intervention and control groups.

The intervention will consist of one-hour massage therapy sessions as follows:

Weeks one through four: twice weekly Weeks five through eight: weekly

Initial treatments are given with greater frequency to “build a loading dose” of massage treatments, effecting a greater impact at the onset of treatment. The preponderance of published studies built in twice-weekly massage for four to five weeks at the onset of treatment (Field, T. et al. Bulimic adolescents benefit from massage therapy. Adolescence 1997 33, 131; Leivadi, S. et al. Massage therapy and relaxation effects on university dance students. Journal of Dance Medicine & Science 1999, 3, 108-112).

Nationally certified and licensed massage therapists who have graduated from an accredited school of massage therapy will give the massage therapy intervention. The therapists will follow standard Swedish full-body therapeutic massage technique. In order to minimize practitioner variability of treatment, a standardized protocol incorporating a sequence of strokes (effleurage, petrissage, tapotement) has been developed (see Appendix E). Subjects will remain supine or prone for the full hour of treatment, turning over roughly at the halfway point.

The second group will begin receiving the identical intervention after the first group has completed its treatment. Weekly phone calls to encourage the second group will be made to minimize attrition. The first group will be followed via phone interviews, with follow-up data collected until the conclusion of the study.

Subjects will be men and women with an established diagnosis of OA meeting ACR criteria, 35 years of age or greater, with a score of 4-9 on a visual analogue scale. Subjects will not be excluded based on gender or race.

Status: Completed (N/A). Started on January 1st, 2003.

Enrollment: 66 subjects

Study Type: Interventional

Study Design:

  • Allocation: Randomized
  • Endpoint Classification: Efficacy Study
  • Intervention Model: Single Group Assignment
  • Masking: Double-Blind
  • Primary Purpose: Treatment

Conditions:

Interventions:

  • Procedure: Massage Therapy

Eligibility

Inclusion Criteria:

  • Radiographically confirmed diagnosis of osteoarthritis

  • 35 years of age or greater

  • pre-randomization VAS score between 4 and 9

Exclusion Criteria:

  • Rheumatoid, arthritis, fibromyalgia, recurrent or active pseudo-gout, cancer or other serious medical condition

  • History of kidney or liver failure

  • Asthma requiring steroids

  • oral steroids within the last four weeks

  • Intra-articular knee depo-corticosteroids within the previous 3 months

  • Intra-articular hyaluronate within the previous 6 months

  • Arthroscopy of the knee within the previous year

  • Significant injury to the knee within the previous 6 months

  • rash or open wound over the knee

Gender

Both

Mininum Age

35 Years

Maximum Age

N/A

Healthy Volunteers

No


Resources

Source: University of Medicine and Dentistry New Jersey

Authority: United States: Federal Government

Locations

  • Saint Barnabas Ambulatory Care Center
    Livingston
    New Jersey
    07039
    United States

Officials

  • Adam I. Perlman, MD, MPH (Principal Investigator, University of Medicine and Dentistry New Jersey)

Sponsors

  • University of Medicine and Dentistry New Jersey (Lead Sponsor)

  • Yale University (Collaborator)

References

None.

Links

None.


Date Verified
January 1st, 2011
First Received
January 31st, 2011
Last Changed
January 31st, 2011

Information obtained from ClinicalTrials.gov on June 09, 2011. Link to the current ClinicalTrials.gov record.


All data in the Healia Clinical Trials Information Database and content displayed by the Healia Clinical Trials Search Engine are licensed from the National Institutes of Health (National Library of Medicine), which collects and maintains the data.

The Healia Clinical Trials Search Engine searches the data set at clinicaltrials.gov, providing up-to-date information about current clinical trials. In the Healia Clinical Trials Database you can find information on new experimental drugs, medical devices, and other types of treatments for all types of diseases. Each clinical trial description includes information about the phase of the trial (phase I, phase II, or phase III), the trial’s methods, such as whether it is a randomized, placebo controlled, double blind study, and the status of the trial including whether or not the trial is currently enrolling new participants.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.